CUSIP: 05360L205
Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,148,320
-
Share change
-
-711,788
-
Total reported value
-
$2,880,334
-
Price per share
-
$2.50
-
Number of holders
-
24
-
Value change
-
-$2,770,389
-
Number of buys
-
11
-
Number of sells
-
27
Quarterly Holders Quick Answers
What is CUSIP 05360L205?
CUSIP 05360L205 identifies ATXI - AVENUE THERAPEUTICS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2021
-
Previous quarter:
Q1 2021
Recent filing periods for CUSIP 05360L205:
Institutional Holders of AVENUE THERAPEUTICS INC - COM NEW (ATXI) as of Q2 2021
As of 30 Jun 2021,
AVENUE THERAPEUTICS INC - COM NEW (ATXI) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,148,320 shares.
The largest 10 holders included
VANGUARD GROUP INC, National Asset Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., EMFO, LLC, Advisory Services Network, LLC, Ergoteles LLC, and Nantahala Capital Management, LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.